Legend Biotech
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $387,500 | $305,100 | $306,377 | $272,330 |
Gross Profit | 250,100 | 129,200 | 182,918 | 157,024 |
EBITDA | 60,100 | -32,000 | -2,150 | -33,194 |
EBIT | 57,700 | -47,600 | -14,118 | -39,073 |
Net Income | 33,200 | -54,300 | -30,815 | -39,689 |
Net Change In Cash | 387,500 | 305,100 | 306,377 | 272,330 |
Free Cash Flow | -41,486 | -111,330 | -126,559 | 23,796 |
Cash | 672,900 | 646,420 | 901,900 | 278,893 |
Basic Shares | 193,800 | 184,733 | 184,733 | 184,636 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,028,900 | $627,241 | $285,143 | $117,005 |
Gross Profit | 620,800 | 392,660 | 140,929 | 51,642 |
EBITDA | -232,300 | -113,159 | -477,873 | -416,536 |
EBIT | -261,200 | -136,518 | -498,324 | -434,928 |
Net Income | -296,800 | -177,026 | -518,254 | -446,349 |
Net Change In Cash | 1,028,900 | 627,241 | 285,143 | 117,005 |
Free Cash Flow | -168,043 | -158,138 | -415,998 | -223,556 |
Cash | 901,900 | 286,749 | 1,277,713 | 786,031 |
Basic Shares | 184,320 | 182,851 | 176,082 | 159,041 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.09 |
2026-03-31 | -$0.15 |
2025-12-31 | -$0.16 |
2025-09-30 | -$0.22 |